Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: TOP1[original query] |
---|
Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 14 (6): 1788-96. Hoskins Janelle M, Marcuello Eugenio, Altes Albert, Marsh Sharon, Maxwell Taylor, Van Booven Derek J, Paré Laia, Culverhouse Robert, McLeod Howard L, Baiget Montserr |
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Pharmacogenomics 2009 Jul 10 (7): 1139-46. Hoskins Janelle M, Rosner Gary L, Ratain Mark J, McLeod Howard L, Innocenti Federi |
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. PloS one 2013 8 (4): e60613. Smith David Hersi, Christensen Ib Jarle, Jensen Niels Frank, Markussen Bo, Rømer Maria Unni, Nygård Sune Boris, Müller Sven, Nielsen Hans Jørgen, Brünner Nils, Nielsen Kirsten Va |
Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers. Molecular oncology 2015 Jun 9 (6): 1207-17. Sønderstrup Ida Marie Heeholm, Nygård Sune Boris, Poulsen Tim Svenstrup, Linnemann Dorte, Stenvang Jan, Nielsen Hans Jørgen, Bartek Jiri, Brünner Nils, Nørgaard Peter, Riis Le |
Genetic variants in microRNAs predict non-small cell lung cancer prognosis in Chinese female population in a prospective cohort study. Oncotarget 2016 Nov . Lingzi Xia, Zhihua Yin, Xuelian Li, Yangwu Ren, Haibo Zhang, Yuxia Zhao, Baosen Zh |
KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer. International journal of cancer 2016 Nov . Nagy Ádám, Pongor L?rinc Sándor, Szabó András, Santarpia Mariacarmela, Gy?rffy Balá |
Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L. Frontiers in pharmacology 2017 8 712. Labriet Adrien, De Mattia Elena, Cecchin Erika, Lévesque Éric, Jonker Derek, Couture Félix, Buonadonna Angela, D'Andrea Mario, Villeneuve Lyne, Toffoli Giuseppe, Guillemette Chant |
Rethinking medulloblastoma from a targeted therapeutics perspective. Journal of neuro-oncology 2018 6 139 (3): 713-720. Hashimoto Yuuri, Penas-Prado Marta, Zhou Shouhao, Wei Jun, Khatua Soumen, Hodges Tiffany R, Sanai Nader, Xiu Joanne, Gatalica Zoran, Kim Lyndon, Kesari Santosh, Rao Ganesh, Spetzler David, Heimberger A |
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer. The pharmacogenomics journal 2019 Dec . Reynolds Ian S, O'Connell Emer, Fichtner Michael, McNamara Deborah A, Kay Elaine W, Prehn Jochen H M, Furney Simon J, Burke John |
Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis. Scientific reports 2019 1 9 (1): 745. Kongkaew Sirilak, Rungrotmongkol Thanyada, Punwong Chutintorn, Noguchi Hiroshi, Takeuchi Fujio, Kungwan Nawee, Wolschann Peter, Hannongbua Sup |
Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy. Frontiers in oncology 2020 4 10 466. Cao Hua, Liu Xinyi, Chen Yixin, Yang Pan, Huang Tanxiao, Song Lele, Xu Ruili |
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science translational medicine 2020 Feb 12 (531): . Coussy Florence, El-Botty Rania, Château-Joubert Sophie, Dahmani Ahmed, Montaudon Elodie, Leboucher Sophie, Morisset Ludivine, Painsec Pierre, Sourd Laura, Huguet Léa, Nemati Fariba, Servely Jean-Luc, Larcher Thibaut, Vacher Sophie, Briaux Adrien, Reyes Cécile, La Rosa Philippe, Lucotte Georges, Popova Tatiana, Foidart Pierre, Sounni Nor Eddine, Noel Agnès, Decaudin Didier, Fuhrmann Laetitia, Salomon Anne, Reyal Fabien, Mueller Christopher, Ter Brugge Petra, Jonkers Jos, Poupon Marie-France, Stern Marc-Henri, Bièche Ivan, Pommier Yves, Marangoni Elisabet |
Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma. BioMed research international 2020 2020 2495157. Meng Hui, Jiang Xuewen, Cui Jianfeng, Yin Gang, Shi Benkang, Liu Qi, Xuan He, Wang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: